FDA Grants Fast Track Designation to Sucampo's Cobiprostone for Oral Mucositis
May 07, 2015 16:42 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., May 7, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA)...
Sucampo Reports First Quarter 2015 Financial Results and Corporate Update
May 06, 2015 06:30 ET
|
Sucampo Pharmaceuticals Inc
Strong Financial Performance Driven by Continued Revenue and Sales Growth of AMITIZA
Strong Growth in Net Income and EPS
Company Confirms 2015 Earnings Guidance
Company to Host Conference Call...
Sucampo Announces First Quarter 2015 Earnings Call
April 22, 2015 06:45 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., April 22, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will host its first quarter 2015...
Sucampo Announces Webcast of Its Presentation at the 14th Annual Needham Healthcare Conference
April 07, 2015 06:45 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., April 7, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate...
Sucampo to Return All Licenses for Unoprostone Isopropyl to R-Tech Ueno
March 09, 2015 02:40 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., March 9, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced it will immediately return all licenses for...
Sucampo Reports Fourth Quarter and Full Year 2014 Financial Results and Corporate Update
March 04, 2015 06:30 ET
|
Sucampo Pharmaceuticals Inc
Strong Year-over-Year Revenue and Sales Growth for AMITIZA
Significant Progress on Pipeline Programs and Strategic Plan
Net Income and EPS Excluding Special Items in Line with 2014 Guidance...
Sucampo Announces Webcast of Its Presentation at the 27th Annual ROTH Conference
March 03, 2015 06:45 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., March 3, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate...
Sucampo Announces Webcast of Its Presentation at the 2015 Cowen and Company Healthcare Conference
February 22, 2015 14:30 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., Feb. 22, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate...
Sucampo Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2014 Earnings Call
February 18, 2015 06:45 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., Feb. 18, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will host its fourth quarter and...
Sucampo Announces Resolution of Par Pharmaceutical's ANDA for RESCULA(R)
February 11, 2015 16:02 ET
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., Feb. 11, 2015 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that Sucampo and R-Tech Ueno, Ltd. (RTU),...